Geode Capital Management
SVNT

Geode Capital Management’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Geode Capital Management’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-308,749
Closed -$193K – 3807
2013
Q3 		$193K Buy
308,749
+332
+0.1% +$212 ﹤0.01% 3322
2013
Q2 		$173K Buy
+308,417
New +$215K ﹤0.01% 3274

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Geode Capital Management's SVNT Position: Q4 2013 in Review

Geode Capital Management sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 308,749 shares — an estimated $193K sold.

Geode Capital Management first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $193K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Geode Capital Management reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Geode Capital Management sold 308,749 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $193K.
  • Geode Capital Management first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Geode Capital Management's SAVIENT PHARMACEUTICALS INC position peaked at $193K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Geode Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.